We have a lap dog. She is bred to be a companion to people and she excels at it. We were going to name her “EPA” after her function (lapdog), but chose a more human name instead. After all, she’s a dog. Despite the fact that she doesn’t get much exercise, she isn’t fat. But obesity is a problem for dogs, too, it seems. So a drug for obesity in dogs is a potential ATM. Nobody sees an ATM like Big Pharma. And their lapdog, the FDA.
A drug specifically designed to treat canine obesity has been approved for the first time by the US Food and Drug Administration.
The drug’s developer, New York-based Pfizer, says the prescription medication will slim dogs, thereby reducing their risk of diseases such as arthritis and cancer. But veterinarians stress that any weight-loss programme for pets must also include lots of exercise and restricted food intake. (New Scientist)
Slentrol comes from Pfizer. I’m glad they are re-investing their hard earned R&D dollars in our nation’s most pressing health problems. You feed your dollars, sorry I mean the drug, directly into your fat pet’s food and it apparently makes them feel full. The FDA’s announcement sounds like the TV ads for prescription drugs:
A veterinarian will determine whether the dog should be treated, based on the dog’s weight and general health. (FDA Press Release)
Then there follows the usual delightful side effects:
Adverse reactions associated with treatment with Slentrol include vomiting, loose stools, diarrhea, lethargy and loss of appetite.
Don’t get me wrong. I understand how hard it is for people to lose weight. But how hard is it to exercise a little portion control on your dog? Shows you what I know:
“A lot of people will take their dog to the fast food joint or drive-through for an ice cream cone or hamburger,” says Bonnie Beaver, former president of the American Veterinary Medical Association. (New Scientist)
I had to read it twice. Is this a great country, or what?